Multispecific peptides
    1.
    发明授权
    Multispecific peptides 有权
    多特异性肽

    公开(公告)号:US08685890B2

    公开(公告)日:2014-04-01

    申请号:US13147289

    申请日:2010-02-04

    IPC分类号: C40B30/04

    摘要: The invention relates to a method for providing a multispecific peptide ligand comprising a polypeptide covalently linked to a molecular scaffold at three or more amino acid residues and capable of binding to two or more separate targets, comprising the steps of: (a) providing a first repertoire of polypeptides, each polypeptide comprising two or more reactive groups capable of covalent linkage to a molecular scaffold, and at least one loop which comprises a sequence of two or more amino acids subtended between two of said reactive groups; (b) providing a second repertoire of polypeptides as described in (a); (c) joining at least one loop of one or more members of the first repertoire to at least one loop of one or more members of the second repertoire to form at least one polypeptide comprising two loops, and (d) conjugating the composite polypeptide(s) to a molecular scaffold at at least three amino acid positions.

    摘要翻译: 本发明涉及一种提供多特异性肽配体的方法,所述多特异性肽配体包含在三个或更多个氨基酸残基处共价连接到分子支架并能够结合两个或更多个单独靶标的多肽,包括以下步骤:(a)提供第一 多肽的所有组成部分,每个多肽包含两个或更多个能够与分子支架共价连接的反应性基团,以及至少一个环,其包含两个或更多个氨基酸的序列,对应于两个所述反应性基团; (b)提供如(a)所述的第二组多肽; (c)将第一组合物中的一个或多个成员的至少一个环连接到第二组合物的一个或多个成员的至少一个环,以形成至少一个包含两个环的多肽,和(d)将复合多肽( s)至少在三个氨基酸位置分子支架。

    MULTISPECIFIC PEPTIDES
    2.
    发明申请
    MULTISPECIFIC PEPTIDES 有权
    多功能肽

    公开(公告)号:US20120101256A1

    公开(公告)日:2012-04-26

    申请号:US13147289

    申请日:2010-02-04

    IPC分类号: C07K17/00 C07K19/00 C12P21/06

    摘要: The invention relates to a method for providing a multispecific peptide ligand comprising a polypeptide covalently linked to a molecular scaffold at three or more amino acid residues and capable of binding to two or more separate targets, comprising the steps of: (a) providing a first repertoire of polypeptides, each polypeptide comprising two or more reactive groups capable of covalent linkage to a molecular scaffold, and at least one loop which comprises a sequence of two or more amino acids subtended between two of said reactive groups; (b) providing a second repertoire of polypeptides as described in (a); (c) joining at least one loop of one or more members of the first repertoire to at least one loop of one or more members of the second repertoire to form at least one polypeptide comprising two loops, and (d) conjugating the composite polypeptide(s) to a molecular scaffold at at least three amino acid positions.

    摘要翻译: 本发明涉及一种提供多特异性肽配体的方法,所述多特异性肽配体包含在三个或更多个氨基酸残基处共价连接到分子支架并能够结合两个或更多个单独靶标的多肽,包括以下步骤:(a)提供第一 多肽的所有组成部分,每个多肽包含两个或更多个能够与分子支架共价连接的反应性基团,以及至少一个环,其包含两个或更多个氨基酸的序列,对应于两个所述反应性基团; (b)提供如(a)所述的第二组多肽; (c)将第一组合物中的一个或多个成员的至少一个环连接到第二组合物的一个或多个成员的至少一个环,以形成至少一个包含两个环的多肽,和(d)将复合多肽( s)至少在三个氨基酸位置分子支架。

    Structured peptide processing
    3.
    发明授权
    Structured peptide processing 有权
    结构肽加工

    公开(公告)号:US08778844B2

    公开(公告)日:2014-07-15

    申请号:US13147257

    申请日:2010-02-04

    IPC分类号: C40B30/04

    摘要: The invention relates to a method for modifying one or more peptide ligands, comprising polypeptides covalently linked to a molecular scaffold at two or more amino acid residues, comprising the steps of providing one or more peptide ligands, wherein the polypeptide comprises two or more reactive groups which form a covalent linkage to the molecular scaffold, and at least one loop which comprises a sequence of two or more amino acids subtended between two of said reactive groups; exposing the peptide ligands to one or more proteases; and sorting the ligands according to the extent of proteolytic cleavage.

    摘要翻译: 本发明涉及一种修饰一种或多种肽配体的方法,其包括在两个或更多个氨基酸残基处与分子支架共价连接的多肽,包括提供一个或多个肽配体的步骤,其中所述多肽包含两个或多个反应性基团 其形成与分子支架的共价键,以及至少一个环,其包含在两个所述反应性基团之间对位的两个或更多个氨基酸的序列; 将肽配体暴露于一种或多种蛋白酶; 并根据蛋白水解切割的程度对配体进行分选。

    Structured Peptide Processing
    4.
    发明申请
    Structured Peptide Processing 有权
    结构肽加工

    公开(公告)号:US20120142541A1

    公开(公告)日:2012-06-07

    申请号:US13147257

    申请日:2010-02-04

    IPC分类号: C40B30/00 C40B40/10

    摘要: The invention relates to a method for modifying one or more peptide ligands, comprising polypeptides covalently linked to a molecular scaffold at two or more amino acid residues, comprising the steps of providing one or more peptide ligands, wherein the polypeptide comprises two or more reactive groups which form a covalent linkage to the molecular scaffold, and at least one loop which comprises a sequence of two or more amino acids subtended between two of said reactive groups; exposing the peptide ligands to one or more proteases; and sorting the ligands according to the extent of proteolytic cleavage.

    摘要翻译: 本发明涉及一种修饰一种或多种肽配体的方法,其包括在两个或更多个氨基酸残基处与分子支架共价连接的多肽,包括提供一个或多个肽配体的步骤,其中所述多肽包含两个或多个反应性基团 其形成与分子支架的共价键,以及至少一个环,其包含在两个所述反应性基团之间对位的两个或更多个氨基酸的序列; 将肽配体暴露于一种或多种蛋白酶; 并根据蛋白水解切割的程度对配体进行分选。

    Peptide libraries
    5.
    发明授权
    Peptide libraries 有权
    肽库

    公开(公告)号:US09518081B2

    公开(公告)日:2016-12-13

    申请号:US13390252

    申请日:2010-08-12

    摘要: The invention relates to a method for altering the conformational diversity of a first repertoire of polypeptide ligands, comprising a plurality of polypeptides comprising at least two reactive groups separated by a loop sequence covalently linked to a molecular scaffold which forms covalent bonds with said reactive groups, to produce a second repertoire of polypeptide ligands, comprising assembling said second repertoire from the polypeptides and structural scaffold of said first repertoire, incorporating one of the following alterations: (a) altering at least one reactive group; or (b) altering the nature of the molecular scaffold; or (c) altering the bond between at least one reactive group and the molecular scaffold; or (d) any combination of (a), (b) or (c).

    摘要翻译: 本发明涉及一种用于改变多肽配体的第一组分的构象多样性的方法,其包含多个多肽,所述多肽包含至少两个反应性基团,所述反应基团通过共价连接到与所述反应性基团形成共价键的分子支架的环序列分开, 以产生多肽配体的第二组成成分,其包括从所述第一组合物的多肽和结构性支架组装所述第二组分,并结合以下改变之一:(a)改变至少一个反应性基团; 或(b)改变分子支架的性质; 或(c)改变至少一个反应性基团和分子支架之间的键; 或(d)(a),(b)或(c)的任何组合。

    PEPTIDE LIBRARIES
    6.
    发明申请
    PEPTIDE LIBRARIES 有权
    肽图书馆

    公开(公告)号:US20120172235A1

    公开(公告)日:2012-07-05

    申请号:US13390252

    申请日:2010-08-12

    摘要: The invention relates to a method for altering the conformational diversity of a first repertoire of polypeptide ligands, comprising a plurality of polypeptides comprising at least two reactive groups separated by a loop sequence covalently linked to a molecular scaffold which forms covalent bonds with said reactive groups, to produce a second repertoire of polypeptide ligands, comprising assembling said second repertoire from the polypeptides and structural scaffold of said first repertoire, incorporating one of the following alterations: (a) altering at least one reactive group; or (b) altering the nature of the molecular scaffold; or (c) altering the bond between at least one reactive group and the molecular scaffold; or (d) any combination of (a), (b) or (c).

    摘要翻译: 本发明涉及一种用于改变多肽配体的第一组分的构象多样性的方法,其包含多个多肽,所述多肽包含至少两个反应性基团,所述反应基团通过共价连接到与所述反应性基团形成共价键的分子支架的环序列分开, 以产生多肽配体的第二组成成分,其包括从所述第一组合物的多肽和结构性支架组装所述第二组分,并结合以下改变之一:(a)改变至少一个反应性基团; 或(b)改变分子支架的性质; 或(c)改变至少一个反应性基团和分子支架之间的键; 或(d)(a),(b)或(c)的任何组合。

    Prevention of aggregation of immunoglobulin light or heavy chains
    10.
    发明授权
    Prevention of aggregation of immunoglobulin light or heavy chains 有权
    防止免疫球蛋白轻链或重链聚集

    公开(公告)号:US08236931B2

    公开(公告)日:2012-08-07

    申请号:US12447908

    申请日:2007-10-26

    摘要: An inhibitor of the aggregation of immunoglobulin chains is provided. The inhibitor may comprise or consist of a polypeptide which comprises or consists of (a) an amino acid sequence corresponding to the amino acid sequence of the FR1 region of an immunoglobulin light chain variable domain, or part thereof which includes amino acid residue 12, (b) an amino acid sequence corresponding to the amino acid sequence of the immunoglobulin-binding domain of bacterial superantigen Protein L, or part thereof, and/or (c) an amino acid sequence corresponding to the amino acid sequence of the immunoglobulin-binding domain of streptococcal protein G, or part thereof, or a variant, fusion or derivative thereof, or a fusion of a variant or derivative thereof which retains the ability of the parent polypeptide to inhibit aggregation of immunoglobulin chains, or domains thereof. Other versions of the inhibitor are also provided.

    摘要翻译: 提供免疫球蛋白链聚集的抑制剂。 抑制剂可以包含或由其组成,其包含(a)对应于免疫球蛋白轻链可变结构域的FR1区的氨基酸序列的氨基酸序列或其部分,其包括氨基酸残基12( b)对应于细菌超抗原蛋白L或其部分的免疫球蛋白结合结构域的氨基酸序列的氨基酸序列和/或(c)对应于免疫球蛋白结合结构域的氨基酸序列的氨基酸序列 的链球菌蛋白G或其部分,或其变体,融合物或衍生物,或其保留母体多肽抑制免疫球蛋白链的聚集或其结构域的能力的变体或衍生物的融合物。 还提供其他版本的抑制剂。